Afuco™ Anti-Human PCSK9 ADCC Therapeutic Antibody (ALD306), ADCC Enhanced

Anti-PCSK9 ADCC Enhanced Antibody (ALD306) is an ADCC enhanced antibody produced by our Afuco™ platform. The humanized mAb recognizes Proprotein convertase subtilisin/kexin type 9 (PCSK9). It can be used to treat cardiovascular dyslipidemia.
Supplier Creative Biolabs
Product # AFC-733CL
Pricing Inquiry
Host Humanized
Target PCSK9
Species Reactivity Human
Type ADCC enhanced antibody
Storage Short term: store at 4°C (over 6 months), long term: -20°C or -80°C.
Feedback